Henry Tsai MD PhD

Henry Tsai MD PhD has had a long and varied career in the medical field. Henry began in 2005 as a Pathologist at APMG. From 2007 to 2009 they were the Medical Director at Kaiser Permanente. From 2009 to 2014 they were the Medical Director at PLUS Diagnostics/Miraca and a Consultant at Abbott Molecular/Rosetta Genomics/Genoptix/Ambry/Neogenomics. From 2014 to 2016 they were the Medical Director at MedLogic/Akrivis/Abbott Laboratories and the CLIA Director at HealthSouth Rehabiltation/Pathex Labs Inc. From 2016 to 2018 they were the Medical Director at MedComp Gx/Element 7/Lab Genomics. Most recently, they have been the Lab Director at Human Longevity, Inc. since 2018.

Henry Tsai MD PhD completed their PhD in Pharmacology and Toxicology from UC Irvine MD/PhD program between 1992 and 1999. Henry then went on to complete their APCP, Surgical Pathology Fellow from UCLA fellowships and residency between 1999 and 2002.